Table 1.
General Hospital Characteristics and Types and Locations of AFST Reported to the National Health Safety Network Patient Safety Component Annual Hospital Survey in 2015
| Automatic or Reflexive Testing, % | |||||||
|---|---|---|---|---|---|---|---|
| Variable | No. of Hospitals a | Any AFST Offered, No. (%) |
AFST Offered at the Hospital’s Own Laboratory or at an Affiliated Medical Center,
No. (%) |
Reflexive AFST Offered,
No. (%) |
Fluconazole, No. (%) |
Other azoles,
No. (%) |
Echinocandins,
No. (%) |
| Medical school affiliation | |||||||
| Yes | 1152 | 1118 (97.0) | 440 (38.2) | 493 (42.8) | 464 (40.3) | 385 (33.4) | 348 (30.2) |
| No | 2205 | 2088 (94.7) | 511 (23.2) | 626 (28.4) | 586 (26.6) | 465 (21.1) | 425 (19.3) |
| Number of beds | |||||||
| 0–100 | 1162 | 1106 (95.2) | 227 (19.5) | 294 (25.3) | 268 (23.1) | 207 (17.8) | 192 (16.5) |
| 101–200 | 903 | 858 (95.0) | 247 (27.4) | 286 (31.7) | 266 (29.5) | 223 (24.7) | 201 (22.3) |
| 201–500 | 1042 | 994 (95.4) | 333 (32.0) | 389 (37.3) | 375 (36.0) | 305 (29.3) | 272 (26.1) |
| >500 | 250 | 248 (99.2) | 144 (57.6) | 150 (60.0) | 141 (56.4) | 115 (46.0) | 108 (43.2) |
| Laboratory | |||||||
| Hospital has own laboratory or affiliated medical center that performs AFST | 951 | 951 (100.0) | N/A | 673 (70.8) | 642 (67.5) | 506 (53.2) | 484 (50.9) |
| Hospital offers AFST via nonaffiliated or commercial laboratory | 2406 | 2255 (93.7) | N/A | 446 (18.5) | 408 (17.0) | 344 (14.3) | 289 (12.0) |
| Candida CLABSI rate per 1000 central line days | |||||||
| 0 | 2017 | 1914 (94.9) | 449 (22.3) | 554 (27.5) | 518 (25.7) | 418 (20.7) | 383 (19.0) |
| Non-0 | 1340 | 1292 (96.4) | 502 (37.5) | 565 (42.2) | 532 (39.7) | 432 (32.2) | 390 (29.1) |
Abbreviations: AFST, antifungal susceptibility testing; CLABSI, central line–associated bloodstream infection.
a3357 of 3438 hospitals (97.6%) had complete survey data and Candida CLABSI rate data from 2015.